Skip to main content

GSA CAPITAL PARTNERS LLP

Position in CRDF — Cardiff Oncology, Inc.

CIK 1362033 LONDON, X0

Position in CRDF

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$199,272
-$393,300 QoQ
Shares Held
123,008
-41.7% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $100,711,343 across 163 Biotechnology names. CRDF ranks #120 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRDF

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $199,272 123,008
2025-12-31 $592,572 210,880
2025-06-30 $408,652 129,731
2025-03-31 $1,113,308 354,557
2024-12-31 $1,649,503 380,070
2024-09-30 $498,355 186,650
2024-06-30 $77,782 35,037
2023-09-30 $36,105 25,975
2023-06-30 $436,115 296,677
2023-03-31 $463,120 280,679
2022-12-31 $493,060 352,186
2022-09-30 $181,525 117,874
2022-06-30 $258,049 117,295
2022-03-31 $158,097 63,749
2021-12-31 $93,227 15,512
2021-06-30 $161,023 24,214